Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy
Clinical trial NCT03826589 · COMPLETED
Trial details
- NCT number
- NCT03826589
- Sponsor
- The University of Hong Kong
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-01
- Primary completion
- 2024-03-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.